Dermsquared

Fall Clinical has sold out. If travel to Vegas isn't in the cards, virtual registration gets you access to the livestream.

First-look data is revealed live, and virtual access means you don't hear it secondhand.

Streaming October 8-11: expert faculty and new clinical data as it's presented, plus up to 18.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™. Watch from your office or anywhere you have a screen and WIFI.

Register at: https://bit.ly/4f9p5UE

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared®. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Nevada, Reno School of Medicine designates this live virtual activity for a maximum of 18.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

A treatment plan can make perfect sense on paper and still go unused.​
​
Jamie Restivo, PA-C, talks with Steve Feldman, MD, PhD, about what really shapes adherence in dermatology, from treatment complexity and perceived inefficacy to the small behavioral cues that can make a routine easier to follow.​
​
They get into the psychology behind why patients may use a medication right before a visit, why accountability can matter as much as another reminder, and how something as simple as where a topical lives in the house can change whether it gets used at all.​
​
Because sometimes the question is whether we chose a treatment that is realistic enough to become part of a patient’s life.​

​
Listen Now: https://bit.ly/3TclKgQ

​

You're the one on hold with the payer. The one who knows a denial letter by heart. The one who gets the medication approved when nobody else can.

The Patient Access Management Summit is built for you. One Saturday, real payer scenarios, hands-on training, and a certification path made for the work you do every day.

Get paid up to $500 for PAMS preparation and ex*****on: $200 for completing the C-PAM 1 credential before you arrive, $200 for attending, $100 for the post-conference survey.

Saturday, December 5, 2026. Orlando, FL.

Secure your spot today: https://bit.ly/4fDPf3A

What should be on your radar when dermatomyositis enters the differential?​

The clues can extend from pruritic scalp disease and nailfold capillary changes to muscle weakness, dysphagia, inflammatory arthritis, and lung involvement, with important implications for malignancy risk and multidisciplinary care.​

In this episode of Derms and Conditions, James Q. Del Rosso, DO, and dermatologist-rheumatologist Joseph Merola, MD, discuss:​

-Cutaneous findings that can help raise suspicion for dermatomyositis​
-Evaluating muscle and other systemic involvement​
-How myositis-specific antibodies can inform assessment of lung disease and malignancy risk​
-Current treatment approaches and emerging targeted therapies​

Listen to the full episode for a clinically focused look at recognizing dermatomyositis, assessing systemic risk, and navigating the diagnostic workup and management.​

Listen Now: https://bit.ly/3SZCc3Z

Spilling the Tea: Important Observations to Help Clinicians James Q. Del Rosso, DO, delivers a solo “Spilling the Tea” segment exploring clinical observations that may warrant a closer look.

Why has sunscreen innovation moved so slowly in the United States, and what does that mean for the products patients use today?​

In a new episode of Derms and Conditions, James Q. Del Rosso, DO, welcomes Darrell Rigel, MD, MS, to discuss the science, regulation, and everyday realities of photoprotection.​

They cover:​
☀️ The regulatory history behind US sunscreen filters​
☀️ Bemotrizinol and what a new UV filter could mean for sunscreen formulations​
☀️ How to address sunscreen misinformation with patients​
☀️ Photoprotection considerations across skin tones​

Tune in for a closer look at the history and science behind modern sunscreens and how dermatologists can navigate common questions about sun protection with their patients.​

​

Listen Now: https://bit.ly/3SCFIRD

​

Sunscreens 2026: The Evolution of Expanded Photoprotection and a New Filter James Q. Del Rosso, DO, welcomes Darrell Rigel, MD, MS, for a discussion of photoprotection and sunscreen regulation.

What might you miss if you stop at the most obvious explanation?​

In this “Spilling the Tea” episode of Derms and Conditions, James Q. Del Rosso, DO, shares clinical observations that highlight the value of looking more closely at findings, labeling, and the full patient picture.​

​
Topics include:​
-Scalp and nailfold findings that may offer clues to dermatomyositis​
-What “not recommended” in prescribing information does, and does not, mean​
-Why a thorough examination matters when assessing active vs fibrotic or scarred disease in HS​

A case of rhabdomyolysis in a patient receiving JAK inhibitor therapy that illustrates why an unexpected finding may have more than one potential explanation​

Tune in for observations that challenge clinicians to look beyond the initial impression and consider what else may be contributing.​

Listen here: https://dermsquared.com/podcasts/derms-and-conditions/season-6-episode-154​

​

Spilling the Tea: Important Observations to Help Clinicians James Q. Del Rosso, DO, delivers a solo “Spilling the Tea” segment exploring clinical observations that may warrant a closer look.